Table 1.
HSC subtypes in the fibrotic PME.
| HSC subtype | Markers | Functions | References |
|---|---|---|---|
| Cytokine and growth factor enriched HSC (cyHSC) | Lowly-activated HSC or Col1a1low. enriched in growth factors (e.g., Rspo3, Hgf) and cytokines (e.g., Cxcl12) | Support hepatocyte survival and regeneration through growth factors and cytokines. | Filliol, A. et al. 2022. [13] |
| Myofibroblastic HSC (myHSC) | Highly-activated HSC Col1a1high express activation markers (e.g., Acta2) and ECM proteins (e.g., Col1a1). | Remodel ECM, increase liver stiffness, and promote pro-tumorigenic changes in advanced fibrosis. | Filliol, A. et al. 2022. [13] Kostallari, E. et al. 2022. [195] Krenkel, O. et al. 2019. [196] |
| Proliferative-HSC | Ki67+ Top2a+ Actively dividing HSCs contributing to population HSC expansion | Expand HSC populations and support fibrotic responses. | Merens, V. et al. 2024. [19] |
| Senescent-HSC | Cell cycle arrest genes (Cdkn1a/p21, Cdkn2a/p16), SA-βGal+, SASP markers, uPAR. | Promote chronic inflammation, alter ECM remodeling, and contribute to fibrosis persistence | Krizhanovsky V. et al. 2008[42] Takahashi A. et al. 2018[43] Burton DG. et al. 2014[44] Yashaswini CN. et al. 2024[45] Yoshimoto S, et al. 2013[46] Lujambio A. et al. 2013[47] Amor C. et al. 2020[48] Li F. et al. 2020[49] |